Income Statement

SCINAI IMMUNOTHERAPEUTICS LTD.

SCNI

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Dec 31, 2022 2022 FY
Revenue	-
Cost of Revenue	-
Gross Profit	-
Operating Expenses	11.06
Research & Development	5.77
Selling, General & Administrative	5.30
Other Operating Expenses	-
Operating Income	-11.06
Non-Operating Income	5.27
Interest Income	-
Interest Expense	-
Other Non-Op Income / Expense	5.10
Income Before Tax	-
Income Tax Expense	-
Non-Controlling Interest	-
Net Income	-5.80

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted